Centessa Pharmaceuticals Income Statement (2022-2025) | CNTA

Income Statement Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue -1.50M-1.65M-1.92M-2.20M-2.35M-2.45M-2.54M-2.57M-2.53M-2.52M-2.56M-2.48M15.00M-2.88M-2.89M
Operating items
Research & Development 36.85M53.65M36.74M27.84M32.83M33.67M28.19M29.72M22.65M32.81M33.90M60.87M33.44M42.74M41.56M
Selling, General & Administrative 14.38M14.76M12.28M13.77M16.05M13.35M12.02M12.31M13.44M11.16M12.50M13.71M12.33M11.91M12.23M
Operating Expenses 51.24M68.41M49.03M41.60M48.88M47.02M40.21M42.03M36.09M43.98M46.41M74.58M45.78M54.65M53.79M
Operating Income -53.22M-68.41M-49.03M-41.60M-48.88M-47.02M-40.21M-35.18M-36.09M-43.98M-46.41M-74.58M-30.78M-54.65M-53.79M
EBIT -53.22M-68.41M-49.03M-41.60M-48.88M-47.02M-40.21M-35.18M-36.09M-43.98M-46.41M-74.58M-30.78M-54.65M-53.79M
Non-operating items
Interest & Investment Income 0.10M0.03M0.08M0.04M2.53M2.06M2.95M2.93M2.59M3.24M3.34M4.84M7.89M4.38M3.77M
Other Non Operating Income 0.20M5.36M-3.14M-0.07M-1.35M-1.53M-1.68M-0.88M-1.54M0.15M3.66M-36.38M1.03M3.59M-1.81M
Non Operating Income 0.20M5.36M-3.14M-0.07M-1.35M-1.53M-1.68M-0.88M-1.54M0.15M3.66M-3.97M1.03M3.59M-1.81M
Net income details
EBT -54.42M-64.68M-54.02M-43.84M-50.04M-48.94M-41.47M-35.69M-37.56M-43.11M-41.96M-110.28M-24.74M-49.56M-54.73M
Tax Provisions 0.08M-0.02M-0.14M-0.66M0.68M-24.05M-2.83M1.14M0.48M0.70M0.61M1.05M1.40M0.78M0.17M
Profit After Tax -54.50M-64.66M-53.88M-43.17M-50.71M-24.89M-38.65M-36.84M-38.05M-43.82M-42.57M-111.33M-26.14M-50.34M-54.89M
Income from Continuing Operations -54.50M-64.66M-53.88M-43.17M-50.71M-24.89M-38.65M-36.84M-38.05M-43.82M-42.57M-111.33M-26.14M-50.34M-54.89M
Consolidated Net Income -54.50M-64.66M-53.88M-43.17M-50.71M-24.89M-38.65M-36.84M-38.05M-43.82M-42.57M-111.33M-26.14M-50.34M-54.89M
Income towards Parent Company -54.50M-64.66M-53.88M-43.17M-50.71M-24.89M-38.65M-36.84M-38.05M-43.82M-42.57M-111.33M-26.14M-50.34M-54.89M
Net Income towards Common Stockholders -54.50M-64.66M-53.88M-43.17M-50.71M-24.89M-38.65M-36.84M-38.05M-43.82M-42.57M-111.33M-26.14M-50.34M-54.89M
Additional items
EPS (Basic) -0.60-0.69-0.57-0.45-0.53-0.26-0.40-0.37-0.38-0.40-0.37-0.91-0.20-0.38-0.41
EPS (Weighted Average and Diluted) -0.60-0.69-0.57-0.45-0.53-0.26-0.40-0.37-0.38-0.40-0.37-0.91-0.20-0.38-0.41
Shares Outstanding (Weighted Average) 94.04M94.34M94.60M94.60M94.96M97.40M97.40M97.63M113.04M113.31M131.85M133.18M133.62M133.62M134.07M
Shares Outstanding (Diluted Average) 90.51M94.11M94.33M93.40M94.94M95.16M96.65M96.18M99.89M109.49M116.25M114.47M133.03M133.68M134.16M
EBITDA -55.20M-65.78M-54.43M-42.98M-49.82M-23.34M-38.81M-36.12M-37.92M-43.84M-42.07M-109.21M-28.27M-50.83M-53.88M
Interest Expenses 1.50M1.65M1.92M2.20M2.35M2.45M2.54M2.57M2.53M2.52M2.56M2.48M2.88M2.88M2.89M
Tax Rate 0.03%0.26%1.51%49.15%6.81%